These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6423033)

  • 1. Prostacyclin--powerful, yes: but is it useful?
    Mitchell JR
    Br Med J (Clin Res Ed); 1983 Dec; 287(6408):1824-6. PubMed ID: 6423033
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostacyclin in vascular pathology--therapeutic possibilities.
    Gryglewski RJ; Szczeklik A
    Ann Clin Res; 1984; 16(5-6):253-61. PubMed ID: 6398663
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical potential of prostacyclin.
    Vane JR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():449-56. PubMed ID: 6221561
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombotic management with a stable prostacyclin analogue during extracorporeal circulation.
    Maurin N
    Contrib Nephrol; 1991; 93():205-9. PubMed ID: 1802582
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostacyclin and prostaglandin E1: molecular mechanisms and therapeutic utility.
    Kerins DM; Murray R; FitzGerald GA
    Prog Hemost Thromb; 1991; 10():307-37. PubMed ID: 1848945
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacology and potential of prostacyclin.
    Lewis PJ; Dollery CT
    Br Med Bull; 1983 Jul; 39(3):281-4. PubMed ID: 6354353
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of iloprost on in vivo and in vitro platelet function in patients with peripheral vascular disease (PVD).
    Fitscha P; Tiso B; Krais T; Sinzinger H
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():450-4. PubMed ID: 2444079
    [No Abstract]   [Full Text] [Related]  

  • 8. Iloprost in peripheral vascular disease--platelet function and clinical outcome.
    Fitscha P; Tiso B; Sinzinger H
    Prog Clin Biol Res; 1987; 242():463-8. PubMed ID: 2444993
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring of in-vivo platelet deposition in patients with peripheral vascular disease after different doses of prostaglandin I2 (PGI2).
    Strobl-Jäger E; Fitscha P; Kaliman J; Sinzinger H
    Prog Clin Biol Res; 1987; 242():403-7. PubMed ID: 3118387
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical benefit and prolongation of platelet half-life induced by CG 4203, a stable PGI2-analogue.
    Kaliman J; Fitscha P; Barth H; Sinzinger H
    Prog Clin Biol Res; 1987; 242():469-77. PubMed ID: 3313421
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of prostacyclin in extracorporeal circulation.
    Ede RJ; Hughes RD; Williams R
    Int J Artif Organs; 1985 Nov; 8(6):297-300. PubMed ID: 3908327
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostacyclin in severe peripheral vascular disease.
    de San Lazaro C; Colver AF; Parkin JM
    Arch Dis Child; 1985 Apr; 60(4):370-2. PubMed ID: 3890767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostacyclin (PGI 2)--an effective antithrombotic].
    Ciko Z
    Vojnosanit Pregl; 1980; 37(3):190-2. PubMed ID: 6996320
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prostacyclin--its function and indications for therapeutic use].
    Ram R; Levy Y; Shoenfeld Y
    Harefuah; 2000 Jan; 138(1):54-8. PubMed ID: 10868182
    [No Abstract]   [Full Text] [Related]  

  • 15. [Extracorporeal circulation with autotransfusion. Use of prostacyclin].
    Fabiani JN; Deloche A; Dubost C; O'grady J
    Nouv Presse Med; 1980 Jun; 9(28):1961-2. PubMed ID: 6999457
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostacyclin and extracorporeal circulation.
    Weston MJ
    Br Med Bull; 1983 Jul; 39(3):285-8. PubMed ID: 6354354
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
    Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
    Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some remarks on the complex behaviour of platelet function during and after prostacyclin treatment.
    Sinzinger H; Silberbauer K; Leithner C; Schwarz M
    Vasa; 1981; 10(4):348-9. PubMed ID: 7032112
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemodialysis with prostacyclin (Epoprostenol) alone.
    Rylance PB; Gordge MP; Ireland H; Lane DA; Weston MJ
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():281-6. PubMed ID: 3887374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic mechanisms of stable prostacyclin (PGI2)-mimetics in severe peripheral vascular disease.
    Müller B; Krais T; Stürzebecher S; Witt W; Schillinger E; Baldus B
    Biomed Biochim Acta; 1988; 47(10-11):S40-4. PubMed ID: 2470358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.